Patients with newly diagnosed heart failure with reduced ejection fraction (HFrEF) commonly have improvements in their LVEF, but that doesn’t mean they can let their guard down, data from a large ...
San Francisco, CA, Dec. 18, 2019 (GLOBE NEWSWIRE) -- Eko, a digital health company applying artificial intelligence (AI) in the fight against heart disease, today announced the U.S. Food and Drug ...
Duke-NUS scientists and their collaborators have discovered a potential new treatment for heart failure with preserved ejection fraction (HFpEF), a type of heart disease that is notoriously difficult ...
By early detection of fluid in the lungs, a device allows early therapy adjustments to reduce all-cause mortality in patients ...
Panelists discuss how ARNIs like sacubitril-valsartan provide superior outcomes compared with ACE inhibitors in HFrEF (20% reduction in cardiovascular events, 16% mortality reduction), with broad FDA ...
In a new research report, a team of scientists led by Johns Hopkins Medicine say people with severe obesity and a common type ...
A collaboration of researchers in Switzerland, Germany, and the US tracked cardiac function in recreational marathon runners over a 10-year span. Repeated endurance training and racing aligned with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results